NRT6003 not checked

Chengdu New Radiomedicine Technology Co. LTD. · Yttrium-90 carbon microspheres

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
1 active
2 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“Patients will be administered NRT6003 Injection via Intra-arterial infusion, and subsequently they will be assessed by PET/CT imaging within 24 hours for its distribution in the chest and upper abdomen, including extrahepatic shunts, intrahepatic distribution, and target lesion distribution as expected.”In the company’s words, NCT06900543 on ClinicalTrials.gov
Tested for
Unresectable Hepatocellular Carcinoma
Main trialPhase 3
“The goal of this clinical trial is to evaluate the efficacy and safety of NRT6003 Injection compared to cTACE in patients with unresectable HCC.”In the company’s words, NCT06900543 on ClinicalTrials.gov
Other names
Yttrium-90 carbon microspheres

Other drugs for Unresectable Hepatocellular Carcinoma

All 130 drugs for Unresectable Hepatocellular Carcinoma

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials2

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting Oct 2027 Chinese HCC Efficacy Evaluation, Response and Safety Study of TareSphere
Phase 1Completed 10 Jun 2025 Safety and Efficacy of TareSphere in Patients With Unresectable Hepatocellular Carcinoma
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow NRT6003

Following is part of Solo: you see every change to NRT6003 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in